Data protection Impressum

Pharma

Backed by its parent company Nanobacterie's fourth-place in nanomedicine patent rankings by Marks and Clerk, AlphaOnco Swiss channels the synergy of Franco-Swiss collaboration to bring forth groundbreaking cancer treatments.

Nanomedicine pioneer Nanobacterie achieves remarkable patent ranking

23 August 2023

EPITERNA focuses on developing therapies that can extend the healthy lifespan of companion dogs, cats, and humans.

Longevity start-up EPITERNA raises EUR 10 million to slow ageing and extend lifespan

7 August 2023

This agreement will ease trade of medicines with the United States and reduce the administrative burden for the industry.

Switzerland and USA implement mutual recognition agreement to streamline pharmaceutical trade

31 July 2023

Top Stories Western Switzerland

Top Stories from Western Switzerland (April-June 2023)

3 July 2023

Merck unveils its cutting-edge Biotech Development Center in Corsier-sur-Vevey

12 June 2023

Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp

7 June 2023

RetinAI partners with Boehringer Ingelheim to improve retinal disease treatment

26 April 2023

Siegfried breaks ground on new global R&D Center for Drug Substances in Evionnaz

26 April 2023

Western Switzerland’s biotech sector flourishes amidst global challenges

26 April 2023

Swiss Biotech Center: innovative solutions for biopharmaceutical development

1 … 3 4 5 6 7 8 9 10 11 … 13